BioCentury
ARTICLE | Clinical News

FluLaval Quadrivalent regulatory update

September 2, 2013 7:00 AM UTC

FDA approved FluLaval Quadrivalent influenza vaccine from GlaxoSmithKline to prevent seasonal influenza A and B infection in people >=3 years. GSK plans to make the intramuscular vaccine available for...